Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Biomarkers to Improve Endoscopic Cancer Surveillance in Individuals With Lynch Syndrome: a Prospective Institutional Study

NCT07838246 is registered in ClinicalTrials.gov with Fondazione IRCCS Istituto Nazionale dei Tumori, Milano as lead sponsor.

NCT NCT07838246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07838246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Biomarkers to Improve Endoscopic Cancer Surveillance in Individuals With Lynch Syndrome: a Prospective Institutional Study
Lead sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase
Observational
Overall status
Completed
Start date
June 20, 2023
Completion date
June 25, 2026
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer (crc), colorectal neoplasms, hereditary nonpolyposis colorectal cancer, hnpcc, lynch syndrome